Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John C. Martin currently holds 7,913 shares of Sarepta Therapeutics, Inc. (SRPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John C. Martin has been a net seller of SRPT stock. They have purchased $1.9M and sold $1.1B worth of shares.
John C. Martin's most recent insider trade was on Mar 3, 2021, when they sold 2,726 shares at $0.00 per share.
John C. Martin serves as Executive at Sarepta Therapeutics, Inc. (SRPT). They have executed 668 insider transactions totaling $1.1B over their tenure at the company.
John C. Martin holds the position of Executive at Sarepta Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
John C. Martin has shown a selling trading pattern, with $1.9M in total purchases and $1.1B in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John C. Martin was on Aug 1, 2018, when they sold $3.9M worth of GILD shares. This transaction involved 50,000 shares at $77.85 per share.
John C. Martin currently owns 7,913 shares of Sarepta Therapeutics, Inc. (SRPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John C. Martin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John C. Martin has 668 Form 4 filings on record as an insider at Sarepta Therapeutics, Inc..
Set alerts for John C. Martin and 40,000+ other insiders.